Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 79,847 | 80,985 | 63,859 | 114,932 | 258,626 |
| Depreciation Amortization | 23,087 | 24,524 | 26,872 | 27,457 | 26,696 |
| Income taxes - deferred | 1,832 | 9,015 | -14,385 | -107 | 4,682 |
| Accounts receivable | 2,265 | -18,565 | 31,584 | 49,261 | 3,486 |
| Accounts payable and accrued liabilities | -1,752 | 8,721 | -1,036 | -13,353 | -3,021 |
| Other Working Capital | -28,991 | -8,485 | 35,202 | 46,997 | -6,666 |
| Other Operating Activity | 35,539 | 28,076 | -10,209 | -6,087 | 19,646 |
| Operating Cash Flow | $111,827 | $124,271 | $131,887 | $219,100 | $303,449 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,859 | -18,073 | -10,616 | -21,477 | -35,702 |
| Net Acquisitions | -47,314 | N/A | -1,242 | -13,774 | -1,200 |
| Purchase Sale Intangibles | -1,190 | -379 | -348 | -1,460 | -854 |
| Other Investing Activity | -2,466 | -2,484 | -2,863 | -4,403 | -5,164 |
| Investing Cash Flow | $-70,639 | $-20,557 | $-14,721 | $-39,654 | $-42,066 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 178,000 | 140,000 | 99,000 | 215,000 | 217,000 |
| Debt Repayment | -114,000 | -130,000 | -316,244 | -139,656 | -128,162 |
| Common Stock Issued | N/A | N/A | 197,202 | N/A | N/A |
| Common Stock Repurchased | -7,451 | -16,909 | -7,161 | -159,709 | -264,368 |
| Dividend Paid | -97,251 | -97,143 | -96,531 | -95,375 | -89,483 |
| Other Financing Activity | -1,770 | -26 | -1,162 | -562 | 1,892 |
| Financing Cash Flow | $-42,472 | $-104,078 | $-124,896 | $-180,302 | $-263,121 |
| Beginning Cash Position | 14,400 | 14,764 | 22,494 | 23,350 | 25,088 |
| End Cash Position | 13,116 | 14,400 | 14,764 | 22,494 | 23,350 |
| Net Cash Flow | $-1,284 | $-364 | $-7,730 | $-856 | $-1,738 |
| Free Cash Flow | |||||
| Operating Cash Flow | 111,827 | 124,271 | 131,887 | 219,100 | 303,449 |
| Capital Expenditure | -21,741 | -18,775 | -11,356 | -22,797 | -36,586 |
| Free Cash Flow | 90,086 | 105,496 | 120,531 | 196,303 | 266,863 |